Skip to main content
Article thumbnail
Location of Repository

Psychological drivers in doping: The life-cycle model of performance enhancement

By Andrea Petróczi and Eugene Aidman
Topics: Hypothesis
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2002). A conceptual framework for achieving performance enhancing drug compliance in sport. Sports Med
  2. (1991). A survey of elite athletes on the perceived causes of using banned drugs in sport.
  3. (1987). A theoretical explanation of why athletes choose to use steroids, and the role of the coach in influencing behaviour.
  4. (2007). A: Current anti-doping policy: a critical appraisal. BMC Med Ethics
  5. (2007). A: Towards an empirical model of performance enhancing supplement use: A pilot study among high performance UK athletes.
  6. Achievement sources of distress among elite athletes. Longitudinal interactions between motivation.
  7. (2005). Adolescent athletes and the demand and supply of drugs to improve performance.
  8. (2002). AG: Mimics: a symbolic conflict/cooperation simulation program, with embedded protocol recording and automatic psychometric assessment. Behav Res Met Instr Comput
  9. (1975). Ajzen I: Belief, attitude, intention and behavior: An introduction to theory and research
  10. (2006). Anabolic Androgenic Steroids: A Survey of 500 Users. Med Sci Sports Exerc
  11. (1993). Anabolic steroid use among students at a British College of Technology.
  12. (1993). Anabolic-androgenic steroid use by private health club/gym athletes.
  13. (2007). Attitudes and doping: A structural equation analysis of the relationship between athletes' attitudes, sport orientation and doping behaviour. Subst Abuse Treat Prev Policy
  14. (1991). Attitudes of elite adolescent Australian athletes toward drug taking: implications for effective drug prevention programs. Drug Educ J Australia
  15. (1997). Australian Sports Drug Agency: The Australian Sports Drug Agency. Survey of elite athletes
  16. (2002). Ayduk O: Self-regulation in a cognitive affective personality system: attentional control in the service of the self. Self & Identity
  17. Ayduk O: Willpower in a cognitive-affective processing system: The dynamics of delay of gratification.
  18. (2001). Balster RL: GHB: a new and novel drug of abuse. Drug Alc Dep
  19. (2007). Beyond medicalisation. Lancet
  20. (1999). Biddle SJH: A review of motivational climate in physical activity.
  21. (2007). Binsinger C: Doping prevalence among preadolescents athletes: a 4-year follow-up.
  22. (1965). Chammah AM:
  23. (2000). Cheong JW: The adolescents training and learning to avoid steroids program. Preventing drug use and promoting health behaviors. Arch Pediatr Adolesc Med
  24. (2005). Colditz GA: Exposure to the mass media, body shape concerns, and use of supplements to improve weight and shape among male and female adolescents. Pediatrics
  25. (1999). Competitors influence each others drug use!" A heuristic use of discriminant analysis to predict drug abuse among Norvegian athletes. Corpus, Psyche et Societas
  26. (2006). Correlates of self-induced vomiting and laxative misuse in a community sample of women.
  27. (2003). Decriminalisation of cannabis use in Switzerland from an international perspective – European, American and Australian experiences.
  28. (2004). Determinants of the intention to use doping substances: an empirical contribution in a sample of Italian adolescents.
  29. DL: Preventing Substance use among High School Athletes: The ATLAS and ATHENA programs.
  30. (1992). Doping games. A game theoretical exploration of doping. Int Rev Sociol Sport
  31. (2006). Doping in fitness sports: estimated number of unreported cases and individual probability of doping. Addiction
  32. (2007). DP: Supplement use in sport: is there a potentially dangerous incongruence between rationale and practice? J Occupat Med Toxicol
  33. (1989). Drug Agency: Australian Sports Medicine Federation. Survey of drug use in Australian sport 2nd edition.
  34. (1997). Drugs and college athlete: an analysis of the attitudes of student athletes at risk. J Drug Educ
  35. (2004). Drugs, recreational drug use and attitudes towards doping of high school athletes. Int J Sports Med
  36. (2006). Dweck CS: Handbook of competence and motivation
  37. (2006). Eating disorders in the male athlete. Curr Op Sp Med
  38. (2007). Elifson K: Functional methamphetamine use: The insider's perspective. Addiction Res Theory
  39. (1997). ER: Adolescent Anabolic-Androgenic steroid use, multiple drug use, and high school sports participation. Pediatric Exerc Sci
  40. (1999). F: Factors associated with adolescent use of doping agents: anabolic-androgenic steroids. Addiction
  41. (2007). Fitch RW: Sports medicine: performanceenhancing drugs.
  42. (2005). From fixed capacities to performanceenhancement: the paradigm shift in the science of 'training' and the use of performance-enhancing substances. Sp History
  43. From intentions to actions: A theory of planned behavior. In Action control: From cognition to behavior Edited by: Kuhl
  44. (2006). GC: Blood doping by cobalt. Should we measure cobalt in athletes?
  45. Great Jews in Sports
  46. (1996). Greenberg L: The use of anabolic-androgenic steroids by Canadian Students.
  47. (1995). GW: Anabolic-Steroid use, strength training, and multiple drug use among adolescents in the United States. Pediatrics
  48. (2007). Herzig RM: Medicalisation in the 21st century: Introduction. Lancet
  49. (2005). Howat P: The barriers to illegal anabolic steroid use. Drugs Educ Prev Policy
  50. (2007). I: Are elite athletes exploited? Sp Society
  51. (2006). JM: The role of drug use outcome expectancies in substance abuse risk: an interactional-transformational model. Addictive Behav
  52. (2004). Kaal HL: The limited relevance of drug policy: cannabis in Amsterdam and in San Francisco.
  53. (1997). KG: Examining athletes' attitudes toward using anabolic steroids and their knowledge of the possible effects. J Drug Educ
  54. (1987). La Fountain MJ: Performance-enhancing drugs in sport. Adolescence
  55. (2003). Landzberg BR: Adverse events associated with dietary supplements: an observational study. Lancet
  56. (1991). Leontiev DA: From being motivated to motivating oneself: A Vygotskian perspective. Studies East Eur Thought
  57. (2006). Loland S: Anti-doping in sport: The Norwegian perspective. Sport in Soc
  58. Measuring Aggression in a Computer Game Simulation.
  59. (2005). Montastruc JL: "Medicamentation" of society, non-diseases and non-medications: a point of view from social pharmacology.
  60. (2005). Motivation in sport: the relevance of competence and achievement goals.
  61. (2003). MP: Anabolicandrogenic steroid use and other adolescent problem behaviours: Rethinking the male athlete assumption. Soc Perspectives
  62. (1999). MW: Risk and protection: are both necessary to understand diverse behavioral outcomes in adolescence? Soc Work Res
  63. (2007). Neumark-Sztainer D: Participation in weight-related sports is associated with higher use of unhealthful weight-control behaviors and steroid use.
  64. (2004). Obadia Y: Attitudes toward doping and recreational use among French elite student-athletes. Soc Sport J
  65. (2003). Obadia Y: Sporting activity and drug use: Alcohol, cigarette and cannabis use among elite student athletes. Addiction
  66. (2002). On the economics of doping and corruption in international sports.
  67. (2007). Outcomes of a prospective trial of student-athlete drug testing: the Student Athlete Testing Using Random Notification (SATURN) study.
  68. (2000). Painkilling Drugs in collegiate athletics: Knowledge, Attitudes, and the use of student athletes.
  69. (2007). Paulussen TGW: Social psychological determinants of the use of performance-enhancing drugs by gym users. Health Educ Res
  70. (2001). Pedersen W: Use of anabolic-androgenic steroids in adolescence: winning, looking good or being bad?
  71. Personality and individual differences in sport.
  72. (2002). Play up, but don't play the game' – English amateur athletic elitism. Sp Historian
  73. (2004). Preventing substance use and disordered eating. Initial outcomes of the ATHENA (Athletes Targeting Healthy Exercise and Nutrition Alternatives) program. Arch Pediatr Adolesc Med
  74. (1994). Psychological Assessment. Appl Psychol Int Rev
  75. (1995). Reinsberger H: Doping and high-level endurance walkers. Knowledge and representation of a prohibited practice. J Sports Med Phys Fitness
  76. (2003). RJ: A new model for understanding performance-enhancing drug use by elite athletes.
  77. (2006). RJ: Why drug testing in elite sport does not work: perceptual deterrence theory and the role of personal moral beliefs.
  78. (1977). Self-efficacy: toward a unifying theory of behavioural change. Psychol Rev
  79. (2005). Shakeshaft A: The management of alcohol, tobacco and illicit drug use problems by general practitioners in Australia. Drug Alcohol Rev
  80. Social capital: implications from an investigation of illegal anabolic steroid networks.
  81. (2004). Sports drug testing – an analyst's perspective. Chem Soc Rev
  82. (2006). Sports Injuries" European Union Group: Sports Injuries European Union Group: Doping use among tertiary education students in six developed countries.
  83. (2006). SR: The association between disordered eating and substance use and abuse in women: a communitybased investigation. Women Health
  84. (1994). Stability of the relationships between anabolic steroid use and multiple substance use among adolescents.
  85. (2006). Steroid and prescription medicine abuse in the health and fitness community: A regional study.
  86. (2006). Taylor CB: Use of diet pills and other dieting aids in a college population with high weight and shape concerns.
  87. (2006). The anti-drugs-in-sport movement: causes for concern.
  88. (1987). The doping dilemma. Sportwissenschaft
  89. (2002). The economics of doping.
  90. (2006). The effect of high school sports participation on the use of performance-enhancing substances in young adulthood.
  91. (2007). The House of Commons, Science and Technology Committee: Human enhancement technologies in sport.
  92. (1989). The incidence of anabolic steroid use among competitive bodybuilders.
  93. (2004). The performance-enhancing drug game.
  94. (2005). The quest for the imaginary evil: a critique of anti-doping.
  95. (2003). The Wide World of Doping: Drug Scandals, Natural Bodies, and the Business of Sports Entertainment. Addiction Res Theory
  96. (1997). To dope or not to dope". A study on the decision to use drugs in Norvegian sports. Corpus, Psyche et Societas
  97. Towards a sociological understanding. Sport Health and Drugs: a critical sociological perspective.
  98. (1990). Tuccimei G: Evaluation of prevalence of "doping" among Italian athletes. Lancet
  99. (1993). Use of multiple drugs among adolescents who use anabolic steroids.
  100. (2004). Using social networs to understand and prevent substance use: a transdisciplinary perspective. Subst Use Misuse
  101. (1988). W: Self-reported use of anabolic androgenic steroids by elite power lifters. Physician Sports Med
  102. (2006). WADA International Conference "Ethics and Social Science Research in Anti-Doping". Deviant Careers: The case of cycling (oral presentation) .
  103. (2007). Whose prometheus? Transhumanism, biotechnology and the moral topography of sports medicine. Sp Ethics Phil
  104. (2004). Why we should allow performance enhancing drugs in sport.
  105. (2001). Wichstrom L: Adolescents, doping agents, and drug use: A community study.
  106. World Anti-Doping Agency (WADA): Word Anti-Doping Code
  107. (2006). Young people and illicit drug use. In Young people, sex and drugs Edited by: Aggleton
  108. (2005). Zur Häufigkeit des Dopings im Leistungssport: Ergebnisse eines www-surveys.". [Doping in elite sports in germany: results of a www survey] Leipziger Sportwissenschaftliche Beiträge

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.